X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs BIOCON LTD - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS BIOCON LTD J.B.CHEMICALS/
BIOCON LTD
 
P/E (TTM) x 14.0 36.7 38.0% View Chart
P/BV x 2.2 4.9 45.2% View Chart
Dividend Yield % 0.2 1.5 11.6%  

Financials

 J.B.CHEMICALS   BIOCON LTD
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
BIOCON LTD
Mar-16
J.B.CHEMICALS/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs318496 64.2%   
Low Rs200397 50.3%   
Sales per share (Unadj.) Rs148.0174.3 84.9%  
Earnings per share (Unadj.) Rs19.144.8 42.6%  
Cash flow per share (Unadj.) Rs23.956.9 42.1%  
Dividends per share (Unadj.) Rs0.505.00 10.0%  
Dividend yield (eoy) %0.21.1 17.2%  
Book value per share (Unadj.) Rs128.9202.8 63.6%  
Shares outstanding (eoy) m84.82200.00 42.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.72.6 68.3%   
Avg P/E ratio x13.610.0 136.2%  
P/CF ratio (eoy) x10.87.8 137.9%  
Price / Book Value ratio x2.02.2 91.2%  
Dividend payout %2.611.2 23.5%   
Avg Mkt Cap Rs m21,95189,220 24.6%   
No. of employees `0002.74.4 61.9%   
Total wages/salary Rs m1,8416,363 28.9%   
Avg. sales/employee Rs Th4,590.97,894.5 58.2%   
Avg. wages/employee Rs Th673.41,441.2 46.7%   
Avg. net profit/employee Rs Th592.12,029.7 29.2%   
INCOME DATA
Net Sales Rs m12,55134,854 36.0%  
Other income Rs m542845 64.1%   
Total revenues Rs m13,09335,699 36.7%   
Gross profit Rs m2,0558,200 25.1%  
Depreciation Rs m4122,423 17.0%   
Interest Rs m96102 93.8%   
Profit before tax Rs m2,0886,520 32.0%   
Minority Interest Rs m0-744 0.1%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m05,754 0.0%   
Tax Rs m4692,569 18.3%   
Profit after tax Rs m1,6198,961 18.1%  
Gross profit margin %16.423.5 69.6%  
Effective tax rate %22.539.4 57.0%   
Net profit margin %12.925.7 50.2%  
BALANCE SHEET DATA
Current assets Rs m7,77839,932 19.5%   
Current liabilities Rs m4,35816,276 26.8%   
Net working cap to sales %27.267.9 40.1%  
Current ratio x1.82.5 72.7%  
Inventory Days Days5554 102.1%  
Debtors Days Days8086 92.9%  
Net fixed assets Rs m5,71339,101 14.6%   
Share capital Rs m1701,000 17.0%   
"Free" reserves Rs m10,54738,591 27.3%   
Net worth Rs m10,93740,556 27.0%   
Long term debt Rs m020,724 0.0%   
Total assets Rs m15,57484,816 18.4%  
Interest coverage x22.864.9 35.2%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.80.4 196.1%   
Return on assets %11.010.7 103.0%  
Return on equity %14.822.1 67.0%  
Return on capital %20.019.0 105.2%  
Exports to sales %48.730.7 158.4%   
Imports to sales %7.120.4 34.7%   
Exports (fob) Rs m6,11510,717 57.1%   
Imports (cif) Rs m8897,105 12.5%   
Fx inflow Rs m6,16911,789 52.3%   
Fx outflow Rs m1,2858,393 15.3%   
Net fx Rs m4,8843,396 143.8%   
CASH FLOW
From Operations Rs m1,3975,264 26.5%  
From Investments Rs m-320-9,540 3.4%  
From Financial Activity Rs m-1,19610,867 -11.0%  
Net Cashflow Rs m-1026,591 -1.6%  

Share Holding

Indian Promoters % 55.4 40.4 137.1%  
Foreign collaborators % 0.3 20.6 1.5%  
Indian inst/Mut Fund % 3.4 8.4 40.4%  
FIIs % 3.9 10.7 36.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 19.9 185.9%  
Shareholders   30,437 109,995 27.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   PLETHICO PHARMA  DIVIS LABORATORIES  ALEMBIC LTD  ALKEM LABORATORIES  ELDER PHARMA  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Biocon: Lower R&D Expenses Help Margin Expansion (Quarterly Results Update - Detailed)

Sep 19, 2016

Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Aug 23, 2017 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS